TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment

NCT00164463 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

FED

Sponsor class

Conditions

Tuberculosis

Interventions

DRUG: Moxifloxacin
DRUG: Isoniazid

Sponsor

Centers for Disease Control and Prevention

Collaborators

[object Object]
[object Object]
[object Object]